The drug in question is called Aducanumab, or Aduhelm.
According to the latest study, the drug slows cognitive decline by 22%.
Experts say this isn't enough, but the FDA and Alzheimer's Association believe it's worth a shot.
What you need to know about the FDA-approved drug for Alzheimer's
Credit: 7News - The Denver Channel
Duration: 00:25s
0 shares
1 views